P Raskin, E Allen, P Hollander, A Lewin, RA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—A total of 209 subjects completed the study. At study end, the mean
HbA 1c value was lower in the BIAsp 70/30 group than in the glargine group (6.91
± 1.17 vs. 7.41 ± 1.24%, P < 0.01). The HbA 1c reduction was greater in ... Cited by 323 - Related articles - All 7 versions
HU Janka, G Plewe, MC Riddle, C Kliebe- … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a 24-week, multinational, multicenter, open,
parallel group clinical trial, 371 insulin-naïve patients with poor glycemic
control (fasting blood glucose [FBG] ≥120 mg/dl, HbA 1c 7.5–10.5%) on ... Cited by 223 - Related articles - All 8 versions
AJ Garber, J Wahlen, T Wahl, P Bressler, R … - Diabetes Obesity and Metabolism, 2006 - epgonline.com Methods: Enrolled patients (n ¼ 100, HbA1c !7.5 and 10%) were !18 years of age,
had diabetes !12 months and had received a stable antidiabetic regimen for at
least 3 months [minimum of two oral antidiabetic drugs (OADs) or at least ... Cited by 141 - Related articles - View as HTML - BL Direct - All 10 versions
MC Riddle, J Rosenstock, J Gerich - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a randomized, open-label, parallel, 24-week
multicenter trial, 756 overweight men and women with inadequate glycemic control
(HbA 1c >7.5%) on one or two oral agents continued prestudy oral agents and ... Cited by 425 - Related articles - BL Direct - All 6 versions
JK Malone, LF Kerr, BN Campaigne, RA … - Clinical therapeutics, 2004 - Elsevier One hundred five patients (mean age, 55 years) were randomized. There was no
difference in baseline mean values for either treatment sequence group for body
mass index, duration of DM, or HbA 1c . Ninety-five patients completed the ... Cited by 52 - Related articles - All 4 versions
- Free from Publisher K Hermansen, M Davies, T Derezinski, G … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—At 24 weeks, A1C had decreased by 1.8 and 1.9% (from 8.6 to 6.8 and
from 8.5 to 6.6%) for detemir and NPH, respectively (NS). In both groups, 70% of
participants achieved an A1C ≤7.0%, but the proportion achieving this ... Cited by 224 - Related articles - BL Direct - All 9 versions
JK Malone, S Bai, BN Campaigne, J Reviriego … - Diabetic Medicine, 2005 - images.medscape.com Results At endpoint, A1c was lower with the insulin lispro mixture plus
metformin compared with glargine plus metformin (7.54% ± 0.87% vs. 8.14% ±
1.03%, P < 0.001). Change in A1c from baseline to endpoint was greater with ... Cited by 68 - Related articles - View as HTML - All 6 versions
H Yki-Järvinen, R Kauppinen-Mäkelin, M … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 442–451 DOI 10.1007/s00125-005-0132-0 ARTICLE H.
Yki-Järvinen . R. Kauppinen-Mäkelin . M. Tiikkainen . M. Vähätalo . ... Cited by 156 - Related articles - BL Direct - All 7 versions
[CITATION] Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of …
- ►diabetesjournals.org L Monnier, H Lapinski, C Colette - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In 290 non–insulin- and non–acarbose-using
patients with type 2 diabetes, plasma glucose (PG) concentrations were
determined at fasting (8:00 am.) and during postprandial and postabsorptive ... Cited by 545 - Related articles - BL Direct - All 5 versions
